Full-text resources of CEJSH and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl

PL EN


2024 | 48(1) | 155-172

Article title

Corporate news disclosure on intangible assets during the COVID-19 crisis in pharmaceutical companies

Content

Title variants

PL
Ujawnianie informacji o wartościach niematerialnych i prawnych w komunikatach spółek farmaceutycznych podczas kryzysu COVID-19

Languages of publication

EN

Abstracts

EN
Purpose: This study explores corporate news communication about intangible assets during the COVID-19 crisis in the largest global pharmaceutical companies. Methodology/approach: Computerised lexical content analysis was performed on 297 articles (texts) from 34 companies, amounting to 280,246 words. We generated a bottom-up cluster-ing of the keywords, titles and abstracts. The qualitative data were obtained from the ProQuest textual database by Clarivate. Findings: The research demonstrates that the biggest global pharmaceutical companies focused intensively on intangible assets during the crisis. They disclosed information on three main intangibles: (1) brand, (2) patent and (3) license, covering 78.17% of the entire corpus text. Research limitations: The study limitations include the fact that the sample concerns only the biggest pharmaceutical companies that met our criteria. Further research could cover small and medium-sized companies and other industries. Finally, further analysis could combine quantitative and qualitative methods within the same research. Originality/value: The research article contributes to the current literature on intangible asset narratives, showing how the biggest pharmaceutical companies tend to achieve a compet-itive advantage, stay successful during a crisis and address messages to their key stakehold-ers. Considering the high risks and existing uncertainties, these messages could be of the utmost importance.
PL
Cel: Celem artykułu jest zbadanie informacji komunikowanych przez największe światowe spółki farmaceutyczne związanych z wartościami niematerialnymi i prawnymi w czasie pandemii COVID-19. Metodyka/podejście badawcze: W artykule przeprowadzono analizę treści 297 artyku-łów (tekstów) z 34 firm, obejmujących 280 246 słów. Przeprowadzono grupowanie słów kluczowych, tytułów i abstraktów. Dane jakościowe uzyskano z bazy danych ProQuest firmy Clarivate. Wyniki: Wyniki badania wykazały, że największe światowe firmy farmaceutyczne w czasie kryzysu intensywnie skupiały się na wartościach niematerialnych i prawnych. Spółki ujawniły informacje dotyczące trzech głównych elementów wartości niematerialnych i prawnych: (1) marki, (2) patentu i (3) licencji, które zajmowały 78,17% całego tekstu. Ograniczenia badawcze: Ograniczeniem artykułu jest fakt, że próba dotyczy wyłącznie największych firm farmaceutycznych. Dalsze badania mogą również objąć mniejsze i średnie przedsiębiorstwa oraz inne branże. Dodatkowo w dalszej analizie można połączyć metody ilościowe i jakościowe. Oryginalność/wartość: Artykuł stanowi rozwinięcie i uzupełnienie istniejącej literatury na temat informacji o wartościach niematerialnych i prawnych oraz tego, w jaki sposób największe firmy farmaceutyczne dążą do osiągnięcia przewagi konkurencyjnej, odnoszą sukcesy w czasie kryzysu i kierują komunikaty do swoich kluczowych interesariuszy. Biorąc pod uwagę wysokie ryzyko i niepewność prowadzenia działalności w sektorze farmaceu-tycznym, informacje te mogą mieć ogromne znaczenie dla spółek.

Contributors

  • Singidunum University, Serbia
author
  • Wroclaw University of Economics and Business, Poland
  • Singidunum University, Serbia

References

  • Akhtaruzzaman M., Boubaker S., Lucey B.M., Sensoy A. (2021), Is gold a hedge or a safe-haven asset in the COVID–19 crisis? “Economic Modelling”, 102 (1), 105588; https://doi.org/10.1016/j.econmod.2021.105588.
  • Albertini E. (2019), Integrated reporting: an exploratory study of French companies, “Jour-nal of Management and Governance”, 23 (2), pp. 513–535; https://doi.org/10.1007/ s10997-018-9428-6.
  • Albertini E. (2021), What are the environmental capabilities, as components of the sustain-able intellectual capital, that matter to the CEOs of European companies? “Journal of Intellectual Capital”, 22 (5), pp. 918–937; https://doi.org/10.1108/JIC-06-2020-0215.
  • Albertini E., Berger-Remy F., Lefrancq S., Morgana L., Petković M., Walliser E. (2021), Voluntary disclosure and intellectual capital: how CEOs mobilise discretionary account-ing narratives to account for value creation stemming from intellectual capital, “Journal of Applied Accounting Research”, 22 (4), pp. 687–705; https://doi.org/10/gjkvwf.
  • Albuquerque R., Koskinen Y., Yang S., Zhang C. (2020), Resiliency of environmental and social stocks: an analysis of the exogenous COVID-19 market crash, “The Review of Cor-porate Finance Studies”, 9 (3), pp. 593–621; https://doi.org/10.1093/rcfs/cfaa011.
  • Aureliano-Silva L., Leung X., Spers E.E. (2021), The effect of online reviews on restaurant visit intentions: applying signaling and involvement theories, “Journal of Hospitality and Tourism Technology”, 12 (4), pp. 672–688; https://doi.org/10.1108/JHTT-06-2020-0143.
  • Aversa D., Adamashvili N., Fiore M., Spada A. (2022), Scoping Review (SR) via Text Data Mining on Water Scarcity and Climate Change, “Sustainability”, 15 (1), 70; https:// doi.org/10.3390/su15010070.
  • Bagna E., Cotta Ramusino E., Denicolai S. (2021), Innovation through patents and intangi-ble assets: effects on growth and profitability of European companies, “Journal of Open Innovation: Technology, Market and Complexity”, 7 (4), pp. 1–19.
  • Bai L., Wei Y., Wei G., Li X., Zhang S. (2021), Infectious disease pandemic and permanent volatility of international stock markets: a long-term perspective, “Finance Research Let-ters”, 40 (1), 101709; https://doi.org/10.1016/j.frl.2020.101709.
  • Baker S.R., Bloom N., Davis S.J., Kost K., Sammon M., Viratyosin T. (2020), The unprece-dented stock market reaction to COVID-19, “The Review of Asset Pricing Studies”, 10 (4), pp. 742–758; https://doi.org/10.1093/rapstu/raaa008.
  • Berman M.G., Stier A.J., Akcelik G.N. (2019), Environmental neuroscience, “American Psychologist”, 74 (9), pp. 1039–1052; https://doi.org/10.1037/amp0000583.
  • Bharathi-Kamath G. (2008), Intellectual capital and corporate performance in Indian pharmaceutical industry, “Journal of Intellectual Capital”, 9 (4), pp. 684–704.
  • Boesso G., Kumar K. (2007), Drivers of corporate voluntary disclosure: A framework and empirical evidence from Italy and the United States, “Accounting, Auditing & Account-ability Journal”, 20 (2), pp. 269–296; https://doi.org/10.1108/09513570710741028.
  • Boguth O., Newton D., Simutin M. (2022), The fragility of organisation capital, “Journal of Financial and Quantitative Analysis”, 57 (3), pp. 857–887; https://doi.org/10.1017/ S0022109021000144.
  • Cerchiello P., Giudici P. (2016), How to measure the quality of financial tweets, “Quality & Quantity”, 50 (4), pp. 1695–1713; https://doi.org/10.1007/s11135-015-0229-6.
  • Crane A., Glozer S. (2016), Researching corporate social responsibility communication: themes, opportunities and challenges, “Journal of Management Studies”, 53 (7), pp. 1223–1252; https://doi.org/10.1111/joms.12196.
  • Cuozzo B., Dumay J., Palmaccio M., Lombardi R. (2017), Intellectual capital disclosure: a structured literature review, “Journal of Intellectual Capital”, 18 (1), pp. 9–28; https://doi.org/10.1108/JIC-10-2016-0104.
  • Dabic M., Vlačic B., Scuotto V., Warkentin M. (2021), Two decades of the Journal of Intel-lectual Capital: a bibliometric overview and an agenda for future research, “Journal of Intellectual Capital”, 22 (3), pp. 458–477; https://doi.org/10.1108/JIC-02-2020-0052.
  • Delios A., Beamish P. (2022), Survival and profitability: the roles of experience and intangi-ble assets in foreign subsidiary performance, “The Academy of Management Journal”, 44 (5), pp. 1028–1038.
  • Demers E., Hendrikse J., Joos P. (2021), ESG did not immunise stocks during the COVID-19 crisis, but investments in intangible assets did, “Journal of Business Finance & Accounting”, 48 (1), pp. 433–462.
  • Ding W., Levine R., Lin C., Xie W. (2021), Corporate immunity to the COVID-19 pandemic, “Journal of Financial Economics”, 141 (2), pp. 802–830; https://doi.org/10.1016/ j.jfineco.2021.03.005.
  • Dost M., Badir Y.F., Ali Z., Tariq A. (2016), The impact of intellectual capital on innovation generation and adoption, “Journal of Intellectual Capital”, 17 (4), pp. 675–695; https://doi.org/10.1108/JIC-04-2016-0047.
  • Dumay J. (2013), The third stage of IC: towards a new IC future and beyond, “Journal of Intellectual Capital”, 14 (1), pp. 5–9; https://doi.org/10.1108/14691931311288986.
  • Eisfeldt A.L., Papanikolaou D. (2013), Organisation capital and the cross-section of ex-pected returns: organisation capital, “The Journal of Finance”, 68 (4), pp. 1365–1406; https://doi.org/10.1111/jofi.12034.
  • Ferguson, A., Kean S., Pündrich G. (2021), Factors Affecting the Value-Relevance of Capitalized Exploration and Evaluation Expenditures Under IFRS 6, “Journal of Accounting, Au-diting & Finance”, 36 (4), pp. 802–825; https://doi.org/10.1177/0148558X20916337.
  • Francis J., Schipper K. (1999), Have financial statements lost their relevance? “Journal of Accounting Research”, 37 (2), pp. 319–352.
  • Goulart G.D.S., Weber A.F., Porto R.B. (2020), Desempenho mercadológico no mercado de alta tecnologia: puma revisão sistemática, “Internext”, 15 (1), 37–52; https://doi.org/ 10.18568/internext.v15i1.535.
  • Gupta K., Goel S., Bhatia P. (2020), Intellectual capital and profitability: evidence from Indian pharmaceutical sector, “Vision”, 24 (2), pp. 204–216.
  • Hasan M.M., Lobo G.J., Qiu B. (2021), Organisational capital, corporate tax avoidance, and firm value, “Journal of Corporate Finance”, 70 (1), 102050; https://doi.org/10.1016/ j.jcorpfin.2021.102050.
  • Hasseldine J., Salama A.I., Toms J.S. (2005), Quantity versus quality: the impact of envi-ronmental disclosures on the reputations of UK Plcs, “The British Accounting Review”, 37 (2), pp. 231–248; https://doi.org/10.1016/j.bar.2004.10.003.
  • Hoffmann A.O.I., Kleimeier S. (2021), Financial disclosure readability and innovative firmsʼ cost of debt, “International Review of Finance”, 21 (2), pp. 699–713; https:// doi.org/10.1111/irfi.12292.
  • Huang Y., Yang S., Zhu Q. (2021), Brand equity and the Covid-19 stock market crash: evidence from U.S. listed firms, “Finance Research Letters”, 43, 101941; https://doi.org/10.1016/ j.frl.2021.101941.
  • Janney J.J., Folta T.B. (2006), Moderating effects of investor experience on the signaling value of private equity placements, “Journal of Business Venturing”, 21 (1), pp. 27–44; https://doi.org/10.1016/j.jbusvent.2005.02.008.
  • Lee W.-J. (2020), A Study on Word Cloud Techniques for Analysis of Unstructured Text Data, “The Journal of the Convergence on Culture Technology”, 6 (4), pp. 715–720; https://doi.org/10.17703/JCCT.2020.6.4.715.
  • Lestari N.I.G., Adhariani D. (2022), Can intellectual capital contribute to financial and non-financial performances during normal and crisis situations? “Business Strategy & Development”, 5 (4), pp. 390–404; https://doi.org/10.1002/bsd2.206.
  • Li B., Siciliano G., Venkatachalam M., Naranjo P., Verdi R.S. (2021), Economic consequenc-es of IFRS adoption: the role of changes in disclosure quality, “Contemporary Accounting Research”, 38 (1), pp. 129–179; https://doi.org/10.1111/1911-3846.12638.
  • Li H., Wang W. (2014), Impact of intangible assets on profitability of Hong Kong listed infor-mation technology companies, “Business and Economic Research”, 4 (2), pp. 98–113.
  • Ma S., Zhang W. (2023), How to improve IFRS for intangible assets? A milestone approach, “China Journal of Accounting Research”, 16 (1), 100289.
  • Marchand P., Ratinaud P. (2012), L’analyse de similitude appliquée aux corpus textuels: Les primaires socialistes pour l’élection présidentielle française, Actes Des 11èmes Journées Internationales d’Analyse Des Données Textuelles (JADT), pp. 687–699.
  • Mehralian G., Rajabzadeh A., Sadeh M., Rasekh H. (2012), Intellectual capital and corpo-rate performance in Iranian pharmaceutical industry, “Journal of Intellectual Capital”, 13 (1), pp. 138–158.
  • Monteiro A.P., Soares A.M., Rua O.L. (2017), Linking intangible resources and export per-formance: The role of entrepreneurial orientation and dynamic capabilities, “Baltic Journal of Management”, 12 (3), pp. 329–347; https://doi.org/10.1108/BJM-05-2016-0097.
  • Moorcraft B. (2020), Lloydʼs exec on how the world has pivoted towards intangible assets, https://www.insurancebusinessmag.com/us/news/breaking-news/lloyds-exec-on-how-the- world-has-pivoted-towards-intangible-assets-232872.aspx.
  • Nemlioglu I., Mallick S.K. (2020), Do innovation-intensive firms mitigate their valuation uncertainty during bad times? “Journal of Economic Behavior & Organization”, 177 (1), pp. 913–940; https://doi.org/10.1016/j.jebo.2020.06.004.
  • Nigam N., Mbarek S., Boughanmi A. (2020), Impact of intellectual capital on the financing of startups with new business models, “Journal of Knowledge Management”, 25 (1), pp. 227–250; https://doi.org/10.1108/JKM-11-2019-0657.
  • Ognjanovic J., Dzenopoljac V., Cavagnetto S. (2023), Intellectual capital before and during COVID-19 in the hotel industry: The moderating role of tangible assets, “Journal of Hospital-ity and Tourism Insights”, ahead-of-print; https://doi.org/10.1108/JHTI-10-2022-0488.
  • Pappu R., Quester P.G. (2016), How does brand innovativeness affect brand loyalty? “European Journal of Marketing”, 50 (1/2), pp. 2–28; https://doi.org/10.1108/EJM-01-2014-0020.
  • Peters R.H., Taylor L.A. (2017), Intangible capital and the investment-q relation, “Journal of Financial Economics”, 123 (2), pp. 251–272; https://doi.org/10.1016/j.jfineco.2016.03.011.
  • Petković M. (2022), What Do the Biggest US Banks Disclosure About Green Intellectual Capital in the Period of COVID-19 Crisis? “Ecologica”, 29 (107), pp. 315–323; https:// doi.org/10.18485/ecologica.2022.29.107.3.
  • Rangel-Perez C., Miquel-Segarra S., Musicco-Nombela D. (2022), The strategic transfer of intangible assets via Twitter by Spanish listed companies in times of crisis, “Romanian Journal of Communication and Public Relations”, 24 (2), pp. 7–22; https://doi.org/ 10.21018/rjcpr.2022.2.341.
  • Riedel N., Spacek M. (2022), Innovation options and profitability of pharmaceutical brand manufacturers, “International Journal of Technology”, 13 (4), pp. 890–899.
  • Rocha de Souza M.A., Lowen Wall M., de Morais Chaves Thuler A.C., Voth Lowen I.M., Peres A.M. (2018), O uso do software IRAMUTEQ na análise de dados em pesquisas qualitativas, “Revista Da Escola de Enfermagem Da USP”, 52; https://doi.org/10.1590/ s1980-220x2017015003353.
  • Sayed E., Mansour K., Hussainey K. (2022), Intangible investment and non-financial per-formance of Egyptian firms: the moderating role of the COVID-19 pandemic, “Journal of Financial Reporting and Accounting”, ahead-of-print.
  • Shneor R., Vik A.A. (2020), Crowdfunding success: A systematic literature review 2010–2017, “Baltic Journal of Management”, 15 (2), pp. 149–182; https://doi.org/10.1108/BJM-04-2019-0148.
  • Simarmata M., Sinaga S., Muda I. (2022), The management company intangible assets governance in pharmaceutical industry, “Journal of Pharmaceutical Negative Results”, 13 (3), pp. 1628–1630.
  • Sriram R.S. (2008), Relevance of intangible assets to evaluate financial health, “Journal of Intellectual Capital”, 9 (3), pp. 351–366; https://doi.org/10.1108/14691930810891974.
  • Uddin M.R., Hasan M.M., Abadi N. (2022), Do intangible assets provide corporate resili-ence? New evidence from infectious disease pandemics, “Economic Modelling”, 110 (1), pp. 1–49, 105806; https://doi.org/10.1016/j.econmod.2022.105806.
  • Venieris G., Naoum V.C., Vlismas O. (2015), Organisation capital and sticky behaviour of selling, general and administrative expenses, “Management Accounting Research”, 26 (1), pp. 54–82; https://doi.org/10.1016/j.mar.2014.10.003.
  • Watson A., Shrives P., Marston C. (2002), Voluntary disclosure of accounting ratios in the UK, “The British Accounting Review”, 34 (4), pp. 289–313; https://doi.org/10.1006/bare. 2002.0213.
  • Widy-Hastuty H., Saragih F., Muda I., Andri Soemitra S. (2023), Valuation and quantifica-tion of assets, liabilities, and income in pharmaceutical company in Indonesia, “Journal of Pharmaceutical Negative Results”, 14 (1), pp. 59–67; doi.org/10.47750/pnr.2023. 14.S01.07.
  • Wong J.B., Zhang Q. (2022), Stock market reactions to adverse ESG disclosure via media channels, “The British Accounting Review”, 54 (1), 101045; https://doi.org/10.1016/j.bar. 2021.101045.
  • Yao N. (Chris), Zhu W., Wei J. (2018), Managing noise in signalling effectiveness: An empirical test of listed companies in China, “Baltic Journal of Management”, 14 (2), pp. 235–249; https://doi.org/10.1108/BJM-12-2017-0389.
  • Yong J.Y., Yusliza M.-Y., Ramayah T., Fawehinmi O. (2019), Nexus between green intellec-tual capital and green human resource management, “Journal of Cleaner Production”, 215 (1), pp. 364–374; https://doi.org/10.1016/j.jclepro.2018.12.306.
  • Zainol A., Nair M., Kasipillai J. (2008), R&D reporting practice: Case of a developing economy, “Journal of Intellectual Capital”, 9 (1), pp. 122–132; https://doi.org/10.1108/14691930 810845849.
  • Zhang Z., Ye Q., Law R., Li Y. (2010), The impact of e-word-of-mouth on the online popularity of restaurants: a comparison of consumer reviews and editor reviews, “International Journal of Hospitality Management”, 29 (4), pp. 694–700; https://doi.org/10.1016/j.ijhm.2010. 02.002/.

Document Type

Publication order reference

Identifiers

YADDA identifier

bwmeta1.element.desklight-32e2ab5c-918c-46c3-b9b7-21bda5c433a1
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.